Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 EP473 | DOI: 10.1530/endoabs.90.EP473

1National Institute of Nutrition of Tunis, Department A, Bab Saadoun, Tunis, Tunisia; 2National Institute of Nutrition of Tunis, Outpatient Department and Functional Explorations, Bab Saadoun, Tunis, Tunisia


Introduction: hyperuricemia is a marker of cardiovascular risk. The aim of this study was to examine the relationship between lipid profile and serum uric acid concentration in patients with type 2 diabetes (T2D).

Method: A retrospective study including 100 patients followed in the A department of the National Institute of Nutrition in Tunis. Data were collected from patients’ medical records. The lipid profile includes low density lipoprotein (LDL), high density lipoprotein (HDL), non high density lipoprotein (non-HDL), triglyceride (TG) and total cholesterol (TC). Hyperuricemia was defined as serum uric acid greater than 6 mg/dl (360 µmol/l).

Results: The mean age of patients was 56.75±12 years ,48% were men and 52% were women. The average duration of diabetes was 8.27±6 years. The mean body mass index (BMI) was 29.55±4.33 kg/m2. Almost one third of the patients (29%) had hyperuricemia (with no clinical manifestations of gout) and 64.5% had dyslipidemia. We found a positive and statistically significant correlation between TG and uric acid level (r=0.45, P0.002). Non-HDL cholesterol was positively correlated with uric acid levels and trend to significance (r=0.28, P0.052). There was no correlation between LDL, HDL and uric acid concentration.

Conclusion: The results of our study illustrate the strong association between uric acid increase and lipid disorder in patients with T2D suggesting a crucial role of uric acid in the regulation of dyslipidemia.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.